Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Targeted Gene Expression Using a 1.1 Kilobase Promoter Fragment of the Tumour-associated Antigen EpCAM

OLIVIER GIRES, STEPHANIE PÖCKL, ROB D. CHAPMAN and MARKUS MÜNZ
Anticancer Research November 2004, 24 (6) 3715-3722;
OLIVIER GIRES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHANIE PÖCKL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROB D. CHAPMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARKUS MÜNZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 24 no. 6 3715-3722
PMID 
15736402

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Published online November 1, 2004.

Copyright & Usage 
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. OLIVIER GIRES1,2,*
  1. 1Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich
  2. 2Clinical Cooperation Group Molecular Oncology, GSF-Research Centre for Environment and Health, and Head and Neck Research Department, Munich
  1. STEPHANIE PÖCKL1,*
  1. 1Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich
  2. 2Clinical Cooperation Group Molecular Oncology, GSF-Research Centre for Environment and Health, and Head and Neck Research Department, Munich
  1. ROB D. CHAPMAN3
  1. 3GSF-National Research Centre for Environment and Health, Marchioninistr.25, D-81377 Munich, Germany
  2. 1Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich
  3. 2Clinical Cooperation Group Molecular Oncology, GSF-Research Centre for Environment and Health, and Head and Neck Research Department, Munich
  1. MARKUS MÜNZ2
  1. 1Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich
  2. 2Clinical Cooperation Group Molecular Oncology, GSF-Research Centre for Environment and Health, and Head and Neck Research Department, Munich
  1. Correspondence to: Olivier Gires, Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich, Germany. Tel: +49-89-7095-3895, Fax: +49-89-7095-6896, e-mail: ogires{at}hno.med.uni-muenchen.de

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 24, Issue 6
Novemeber-December 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Targeted Gene Expression Using a 1.1 Kilobase Promoter Fragment of the Tumour-associated Antigen EpCAM
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Targeted Gene Expression Using a 1.1 Kilobase Promoter Fragment of the Tumour-associated Antigen EpCAM
OLIVIER GIRES, STEPHANIE PÖCKL, ROB D. CHAPMAN, MARKUS MÜNZ
Anticancer Research Nov 2004, 24 (6) 3715-3722;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Targeted Gene Expression Using a 1.1 Kilobase Promoter Fragment of the Tumour-associated Antigen EpCAM
OLIVIER GIRES, STEPHANIE PÖCKL, ROB D. CHAPMAN, MARKUS MÜNZ
Anticancer Research Nov 2004, 24 (6) 3715-3722;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Targeted Sensitization of Leukemic T-cells to Anticancer Drugs by SIRT1 Agonist SRT-1720
  • Alteration of Flavin Homeostasis in Uterine Cancer
  • Prognostic Significance of PPFIA2 in Localized Prostate Cancer: Integrative Analysis and Functional Validation
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire